Organon & Co. (OGN) Stock Forecast, Price & News

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Organon & Co. in the last twelve months. There are currently 1 sell rating, 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" OGN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OGN, but not buy additional shares or sell existing shares.
View OGN analyst ratings or view top-rated stocks.

4 brokerages have issued 12 month target prices for Organon & Co.'s stock. Their OGN share price forecasts range from $24.00 to $34.00. On average, they predict the company's share price to reach $29.00 in the next year. This suggests a possible upside of 48.4% from the stock's current price.
View analysts price targets for OGN or view top-rated stocks among Wall Street analysts.

Organon & Co.'s stock was trading at $27.93 on January 1st, 2023. Since then, OGN stock has decreased by 30.0% and is now trading at $19.54.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 3rd 2023.
View our OGN earnings forecast.

Organon & Co. (NYSE:OGN) issued its quarterly earnings results on Thursday, May, 4th. The company reported $1.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.18 by $0.10. The business had revenue of $1.54 billion for the quarter, compared to analysts' expectations of $1.54 billion. Organon & Co. had a negative trailing twelve-month return on equity of 119.00% and a net margin of 12.14%. The firm's revenue for the quarter was down 1.9% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.65 EPS.
Read the conference call transcript.

Organon & Co. announced a quarterly dividend on Thursday, May 4th. Shareholders of record on Monday, May 15th will be paid a dividend of $0.28 per share on Thursday, June 15th. This represents a $1.12 dividend on an annualized basis and a dividend yield of 5.73%. The ex-dividend date of this dividend is Friday, May 12th.
Read our dividend analysis for OGN.

ETFs with the largest weight of Organon & Co. (NYSE:OGN) stock in their portfolio include Timothy Plan Market Neutral ETF (TPMN), Invesco S&P Spin-Off ETF (CSD), SPDR S&P Pharmaceuticals ETF (XPH), Direxion Daily Pharmaceutical & Medical Bull 3X Shares (PILL), Emerge EMPWR Sustainable Dividend Equity ETF (EMCA), iShares U.S. Pharmaceuticals ETF (IHE), First Trust Nasdaq Pharmaceuticals ETF (FTXH) and ALPS Sector Dividend Dogs ETF (SDOG).

Organon & Co. (NYSE:OGN) pays an annual dividend of $1.12 per share and currently has a dividend yield of 5.73%. OGN has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 38.36%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, OGN will have a dividend payout ratio of 24.62% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for OGN.

Organon & Co. updated its FY 2023 earnings guidance on Thursday, May, 4th. The company provided EPS guidance of for the period. The company issued revenue guidance of $6.15 billion-$6.45 billion, compared to the consensus revenue estimate of $6.29 billion.

Organon & Co. trades on the New York Stock Exchange (NYSE) under the ticker symbol "OGN."

Organon & Co.'s stock is owned by a variety of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (6.36%), Mawer Investment Management Ltd. (5.20%), State Street Corp (5.03%), Bank of New York Mellon Corp (2.14%), Geode Capital Management LLC (2.13%) and Sound Shore Management Inc. CT (1.31%).
View institutional ownership trends.

Shares of OGN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of OGN stock can currently be purchased for approximately $19.54.

Organon & Co. (NYSE:OGN) has a market capitalization of $4.98 billion and generates $6.17 billion in revenue each year. The company earns $917 million in net income (profit) each year or $2.92 on an earnings per share basis.

The company employs 10,000 workers across the globe.

Organon & Co.'s mailing address is 2000 Galloping Hill Road, Kenilworth, New Jersey 07033. The official website for the company is www.organon.com. The company can be reached via phone at 551-430-6900 or via email at investor_relations@organon.com.